239 related articles for article (PubMed ID: 28299760)
41. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract][Full Text] [Related]
42. Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival.
Bernard B; Clarke BA; Malowany JI; McAlpine J; Lee CH; Atenafu EG; Ferguson S; Mackay H
Gynecol Oncol; 2013 Dec; 131(3):634-9. PubMed ID: 24135678
[TBL] [Abstract][Full Text] [Related]
43. Uterine sarcoma: 14 years experience in KCCC.
Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
[TBL] [Abstract][Full Text] [Related]
44. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
45. A contemporary review of uterine cancer management.
Carter J
Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):517-24. PubMed ID: 23829412
[TBL] [Abstract][Full Text] [Related]
46. Endometrial stromal sarcoma of the uterus.
Meden H; Meyer-Rath D; Schauer A; Kuhn W
Anticancer Drugs; 1991 Feb; 2(1):35-7. PubMed ID: 1958850
[TBL] [Abstract][Full Text] [Related]
47. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Piver MS; Lele SB; Marchetti DL; Emrich LJ
J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
[TBL] [Abstract][Full Text] [Related]
48. Undifferentiated uterine sarcoma: a rare, not well known and aggressive disease: report of 13 cases.
Ríos I; Rovirosa A; Morales J; Gonzalez-Farre B; Arenas M; Ordi J; Pahisa J; Biete A
Arch Gynecol Obstet; 2014 Nov; 290(5):993-7. PubMed ID: 24958349
[TBL] [Abstract][Full Text] [Related]
49. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
Pautier P; Nam EJ; Provencher DM; Hamilton AL; Mangili G; Siddiqui NA; Westermann AM; Reed NS; Harter P; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S73-7. PubMed ID: 25341584
[TBL] [Abstract][Full Text] [Related]
50. [Clinical aspects of uterine sarcomas (author's transl)].
Stegner HE
Pathol Res Pract; 1980 Oct; 169(2):120-6. PubMed ID: 7443570
[TBL] [Abstract][Full Text] [Related]
51. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
52. The role of adjuvant therapy in uterine leiomyosarcoma.
Ducie JA; Leitao MM
Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
[TBL] [Abstract][Full Text] [Related]
53. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
[TBL] [Abstract][Full Text] [Related]
54. Different types and different prognosis-study of 310 uterine sarcomas.
Nickie-Psikuta M; Gawrychowski K
Eur J Gynaecol Oncol; 1993; 14 Suppl():105-13. PubMed ID: 8200360
[TBL] [Abstract][Full Text] [Related]
55. A clinical and pathologic study of 34 sarcomas of the uterus.
Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
[TBL] [Abstract][Full Text] [Related]
56. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980.
De Fusco PA; Gaffey TA; Malkasian GD; Long HJ; Cha SS
Gynecol Oncol; 1989 Oct; 35(1):8-14. PubMed ID: 2792908
[TBL] [Abstract][Full Text] [Related]
57. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
59. Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.
Visnovsky J; Kudela E; Slavik P; Krkoska M; Buocik P; Szepe P; Danko J
Neuro Endocrinol Lett; 2015; 36(8):750-7. PubMed ID: 26921575
[TBL] [Abstract][Full Text] [Related]
60. Role of radiotherapy treatment of uterine sarcoma.
Sampath S; Gaffney DK
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
